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Abstract
Enteroviruses (EVs) are among the most commonly detected viruses infecting humans worldwide. Although the prevalence 
of EVs is widely studied, the status of EV prevalence in sub-Saharan Africa remains largely unknown. The objective of 
our present study was therefore to increase our knowledge on EV circulation in sub-Saharan Africa. We obtained 749 fecal 
samples from a cross-sectional study conducted on Malawian children aged 6 to 60 months. We tested the samples for the 
presence of EVs using real time PCR, and typed the positive samples based on partial viral protein 1 (VP1) sequences. A 
large proportion of the samples was EV positive (89.9%). 12.9% of the typed samples belonged to EV species A (EV-A), 
48.6% to species B (EV-B) and 38.5% to species C (EV-C). More than half of the EV-C strains (53%) belonged to subgroup 
C containing, among others, Poliovirus (PV) 1-3. The serotype most frequently isolated in our study was CVA-13, followed 
by EV-C99. The strains of CVA-13 showed a vast genetic diversity, possibly representing a new cluster, ‘F’. The major-
ity of the EV-C99 strains grouped together as cluster B. In conclusion, this study showed a vast circulation of EVs among 
Malawian children, with an EV prevalence of 89.9%. Identification of prevalences for species EV-C comparable to our study 
(38.5%) have only previously been reported in sub-Saharan Africa, and EV-C is rarely found outside of this region. The data 
found in this study are an important contribution to our current knowledge of EV epidemiology within sub-Saharan Africa.
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Introduction
Genus Enterovirus is a member of the family of Picornaviri-
dae and consists of 13 species of which 7 classify as viruses 
which infect humans, i.e. Enterovirus A-D and Rhinovirus 
A-C [1]. Enteroviruses (EV’s) are known to cause a wide 
variety of clinical symptoms, ranging from mild respiratory 
infections to invasive disease such as meningitis, encepha-
litis and acute flaccid paralysis (AFP). Systematic surveil-
lance programs have led to an increased knowledge on EV 
circulation in large parts of the world. In Europe and the 
United States, EVs are found in 5-12% of clinical samples 
[2–6]. Most of the EV strains found in Europe and the USA 
belong to species B, while species A is dominant in Asia 
[2, 3, 5, 7–12]. Regular outbreaks of EVs causing severe 
disease and complications, such as EV-A71 and EV-D68, 
have been reported in various countries in North-America, 
Europe and Asia, as well as in Australia [13, 14]. The sta-
tus of EV prevalence in sub-Saharan Africa remains largely 
unknown, due to incomplete sampling or data collection. 
The few data available report a high EV prevalence – up 
to 50% – with an EV-C proportion of up to 76% amongst 
circulating EV strains [15–28].
Poliovirus (PV) is the most well-known EV causing AFP 
[29, 30]. Global vaccination programs have significantly 
reduced the incidence of PV infections, with PV now being 
endemic in only three countries (Afghanistan, Pakistan and 
Nigeria) [31]. PV belongs to species EV-C, and attenuated 
PV, as administered in the oral polio vaccine (OPV), can 
recombine with other strains belonging to EV-C to form vac-
cine-derived poliovirus (VDPV) [32–35]. Outbreaks of such 
VDPVs causing polio-like symptoms have been reported 
in the Philippines, Madagascar, the Dominican Republic, 
Haiti, Cambodia, Nigeria and Egypt [32, 36–40]. A high 
prevalence of EV-C in sub-Saharan Africa could increase 
the chances of VDPV’s arising in this continent.
The aim of this study was to provide further insights into 
the prevalence of EVs in children in sub-Saharan Africa, 
to assess the distribution of species EV-A, -B and –C, and 
finally to examine the genetic variability within the circulat-
ing species and genotypes. For this, we used fecal samples 
obtained in a case-control study conducted on children in 
Malawi. We report a high frequency of EVs classifiable as 
subgroup C of species C, a group that also contains PV.
Materials and methods
Patients and samples
A total of 749 fecal samples obtained from children included 
in the case-control SevAna (Severe Anemia) study in South-
ern Malawi between 2002 and 2004 were included in this 
study. The SevAna study was ethically approved and has 
been described in detail previously [41]. The samples used 
in our analyses were obtained from patients with: severe 
anemia (hemoglobin < 5 g/dl), hospital controls without 
severe anemia and randomly selected community controls. 
All included participants were between 6 and 60 months 
of age. A questionnaire, including date of birth, sex, date 
of recruitment and discharge and clinical symptoms, was 
completed for each participant. Fecal samples were stored 
at -20 °C and shipped to Leiden University Medical Center, 
the Netherlands. After storage for 10 years, the remaining 
samples were brought to the Academic Medical Center, 
Amsterdam for continued storage at -20 °C.
Virus isolation and detection
The Boom nucleic acid extraction method was used to iso-
late RNA from each sample [42]. RT-PCR was performed as 
described previously using primers EV-1 and EV-2 to deter-
mine presence of EV in the samples (Table 1) [43]. Samples 
with a Ct-value < 40 were considered to be EV positive. 
Samples with a Ct-value < 30 were included for sequencing.
Enterovirus typing and phylogenetic analysis
A sensitive, semi-nested PCR amplification of VP1 
sequences was performed, including primers 224 and 222 
Table 1  Primers and probes 
used for RT-PCR (primers 
EV-1, EV-2 and probe 
WT-MGB), semi-nested PCR 
(primers 224, 222, AN89 and 
AN88) and sequencing (primers 
AN89 and AN88)
Primer/probe Sequence 5’-3’ Polarity Gene Genomic location
224 GCIATGYTIGGIACICAYRT Forward VP1 1977-1996
222 CICCIGGIGGIAYR WAC AT Reverse VP1 2969-2951
AN89 CCA GCA CTG ACA GCAGYNGARAYNGG Forward VP1 2602-2627
AN88 TAC TGG ACC ACC TGGNGGNAYR WAC AT Reverse VP1 2977-2951
EV-1 GGC CCT GAA TGC GGC TAA T Forward 5’UTR 450-468
EV-2 GGG ATT GTC ACC ATA AGC AGCC Reverse 5’UTR 600-579
WT-MGB (probe) CGG AAC CGA CTA CTT TGG GT 5’UTR 532-551
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for the first PCR and primers AN89 and AN88 for the sec-
ond PCR, as described previously (Table 1) [44]. The size 
of the PCR fragments was analyzed by gel electrophore-
sis. Positive samples with a PCR fragment size of ~ 350 
to 400 base pairs (bp) were selected and sequenced using 
the BigDye Terminator kit, together with primers AN89 
and AN88. CodonCode Aligner was used to assemble the 
obtained sequences. The sequences were typed using the 
online RIVM enterovirus genotyping tool (National Institute 
for Public Health and the Environment, http://www.rivm.nl/
mpf/typin gtool /enter oviru s/ accessed 1st December 2014) 
and by comparison with reference strains in GenBank using 
BLAST (NCBI, https ://blast .ncbi.nlm.nih.gov/ accessed 1st 
December 2014). The VP1 sequences obtained in this study 
were aligned with GenBank reference strains for respective 
genotypes, using ClustalX2 software. Neighbor-joining trees 
were constructed of study strains and reference strains, using 
the p-distance model implemented in MEGA 6 Software. 
One thousand bootstrap replicates were used to test the sup-
port for branches within the tree.
The nucleotide sequence data reported in this paper 
will appear in the DDBJ/EMBL/GenBank nucleo-
tide sequence databases with the accession numbers 
MG793383-MG793425.
Statistical analysis
Baseline characteristics were calculated as frequencies 
and percentages for categorical variables, and as median 
and interquartile range (IQR) for numerical variables. We 
examined associations between EV positivity and the vari-
ables sex, inclusion group and age by Fisher’s exact test 
and Mann-Whitney-U test. Within the community control 
group, we examined the association between possible EV-
related symptoms (i.e. gastro-intestinal symptoms, respira-
tory symptoms, central nervous system symptoms and fever) 
and EV infection using logistic regression analysis, and cor-
rected for sex and age. Since 38.2% of the community con-
trol group was diagnosed with malaria, we also corrected for 
diagnosis of malaria. All statistical analyses were performed 
using IBM SPSS Statistics 24. Correlations were considered 
to be significant at an alfa-level of 0.05 or lower.
Results
EV prevalence in Malawian children
The baseline characteristics of the study participants are 
shown in Table 2. Baseline characteristics, sex and median 
age were comparable among the three inclusion groups.
Overall, 673 of the 749 fecal samples (89.9%) tested posi-
tive for EV targeting the 5’UTR by qPCR. Of 437 samples 
included for genotyping, good quality sequences could be 
retrieved from 283/437 (65%) of samples (Figure 1). In 
total, we found 59 different genotypes (Table 3). Entero-
virus B was the most frequently detected species, followed 
Table 2  Baseline characteristics
Cases with severe ane-
mia, n = 227
Hospital controls, n = 261 Community controls, 
n = 249
Totala (n = 749)
Patient characteristics
 Male sex, n (%) 107 (47) 133 (51) 120 (48) 371 (50)
 Age in years, median (IQR) 1.30 (0.85-2.16) 1.76 (1.06-2.39) 2.00 (1.20-3.01) 1.64 (1.02-2.60)
 EV-positive, n (%) 198 (87) 234 (90) 229 (92) 673 (90)
Sequenced, n (%)b 77/198 (39%) 104/234 (44%) 99/229 (43%) 283/673 (42%)
 EV-A, n (%) 15 (19) 8 (8) 15 (15) 38 (13)
 EV-B, n (%) 37 (48) 58 (56) 40 (40) 137(48)
 EV-C, n (%) 25 (32) 38 (37) 44 (44) 108 (38)
Fig. 1  Flowchart for all the included samples
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by Enterovirus C and Enterovirus A (53%, 34% and 13%, 
respectively) (Table 3). No Enterovirus D was detected.
Within EV-B, the most frequently detected genotypes 
were echovirus 6 (10/286, 3.5%) and echovirus 15 (12/286, 
4.2%), while several of the higher numbered EV-B geno-
types were also detected (EV-B69-100). In EV-C, CV-A13 
(34/286, 11.9%) and EV-C99 (31/286 10.8%) were the most 
frequently detected genotypes. EV-A119 (8/286, 2.8%) and 
CVA6 (5/286, 1.7%) were the genotypes most frequently 
detected within EV-A (Table 1). One PV2-strain and one 
PV3-strain were identified, both of which were shown to 
have a ≥ 98.6% match to their respective reference Sabin 
strains in GenBank, indicating that these are vaccine-like 
polioviruses.
Enterovirus C has previously been divided into subgroups 
A, B and C [45]. Of all the typed EV-C strains in our study, 
53% belonged to subgroup C, 35% to subgroup B and 12% 
to subgroup A.
EV prevalence was not associated with age (p = 0.882), 
sex (p = 0.629) or study group (p = 0.250). Within the com-
munity control group, the reporting of possible EV-related 
symptoms was not correlated with EV infection (p = 0.531).
Genetic diversity of EV‑C strains
Figure 2 shows the genetic relationship of our Malawian 
EV-C strains with respective reference strains obtained from 
GenBank.
Table 3  List of all typed strains
No. of typed strains % of all 
typed 
strains
Species and type
HEV-A
 CVA-2 2 0.7%
 CVA-4 2 0.7%
 CVA-5 4 1.4%
 CVA-6 5 1.7%
 CVA-7 1 0.3%
 CVA-8 2 0.7%
 CVA-10 2 0.7%
 CVA-14 1 0.3%
 CVA-16 2 0.7%
 EV-A76 3 1.0%
 EV-A89 2 0.7%
 EV-A119 8 2.8%
 EV-A120 3 1.0%
All HEV-A 37 12.9%
HEV-B
 CVA-9 9 3,1%
 CVB-2 1 0.3%
 CVB-4 1 0.3%
 CVB-5 1 0.3%
 E1 7 2.4%
 E2 2 0.7%
 E5 5 1.7%
 E6 10 3.5%
 E7 4 1.4%
 E9 1 0.3%
 E11 4 1.4%
 E12 1 0.3%
 E13 7 2.4%
 E14 9 3.1%
 E15 12 4.2%
 E18 6 2.1%
 E19 5 1.7%
 E20 3 1.0%
 E21 4 1.4%
 E24 1 0.3%
 E25 3 1.0%
5 1.7%
 E29 4 1.4%
 E33 4 1.4%
 EV-B69 1 0.3%
 EV-B73 1 0.3%
 EV-B75 5 1.7%
 EV-B78 4 1.4%
 EV-B79 2 0.7%
 EV-B82 4 1.4%
 EV-B80 8 2.8%
Table 3  (continued)
No. of typed strains % of all 
typed 
strains
 EV-B88 2 0.7%
 EV-B97 1 0.3%
 EV-B100 2 0.7%
 All HEV-B 139 48.6%
HEV-C
 CVA-1 9 3,1%
 CVA-11 7 2.4%
 CVA-13 34 11.9%
 CVA-17 3 1.0%
 CVA-19 1 0.3%
 CVA-20 12 4.2%
 CVA-24 8 2.8%
 EV-C99 31 10.8%
 EV-C116 3 1.0%
 PV2 (Sabin-like) 1 0.3%
 PV3 (Sabin-like) 1 0.3%
 All HEV-C 110 38.5%
All typed strains 286 100%
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All strains grouped with their corresponding reference 
strains into type-specific clusters with strong bootstrap 
support (Figure 2). The nucleotide (nt) and amino acid 
(aa) identity within the serotypes was ≥ 75% and ≥ 88% 
respectively for all types except for CVA-13. For CVA-13 it 
was ≥ 70.0% and ≥ 84.3%, respectively.
As reported previously, the CVA-13 sequences grouped 
into clusters A to D, with ≥ 79.2% and ≥ 91.7% nt and aa 
Fig. 2  Phylogenetic relationships, based on the VP1 3’ terminal 
nucleotide sequences, for Malawian field strains and reference strains 
available in GenBank. Supportive percentage bootstrap replicates 
≥ 85% are shown. Studied strains are indicated by circles. For refer-
ence strains, the location and year of isolation are indicated (DR 
Congo, Democratic Republic of the Congo; CAR, Central African 
Republic). The prototype strains are indicated by triangles. Cluster F 
is marked in light grey to indicate that this is a potential new cluster, 
based on the nt and aa percentage similarity to the other clusters
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identity within each of these clusters (Table 4) [27, 46]. Five 
of the Malawian CVA-13 sequences clustered with strains 
from the Central African Republic and the Democratic 
Republic of the Congo in CVA-13 Cluster D (bootstrap 
value 100%). The nt and aa identity within this cluster was 
≥ 81.5% and ≥ 91.5%, respectively (Table 4). The nt and 
aa identity of cluster D compared to the other clusters was 
69.3%-73.3% and 79.7%-89.2%, respectively, whereas the 
identity scores between clusters A, B, C and E were 71.3%-
77.3% for nt, and 81.2%-94.0% for aa identity (Table 4).
Furthermore, seven Malawian CVA-13 strains, as well as 
several reference strains, did not belong to a known cluster. 
Of these, six of our sequences clustered together, supported 
by a bootstrap value of 99%, suggesting a new cluster, ‘F’ 
(Figure 2). The nt and aa identity within this cluster was 
89.1%% and 95.3% respectively, while the nt and aa identity 
compared to the other clusters was 69.0%-77.0% and 82.4%-
94.6% respectively (Table 4).
EV-C99 is known to consist of three clusters, i.e. A, B 
and C [27, 46], supported by bootstrap values of 96%, 5% 
and 97% respectively in our phylogram. Our strains did not 
group with any of the clusters. Three of our strains (03-
1265, 03-1202 and 04-4491) were most similar to cluster C 
(≥ 80.8% nt identity and ≥ 92.6% aa identity). The remaining 
seven strains were most closely related to cluster B (≥ 80.8% 
nt identity and ≥ 94.9% aa identity).
Discussion
Our study contains new information about EV epidemiology 
and genetic diversity within sub-Saharan Africa, which con-
tributes to our knowledge on EV-C circulation. Since epide-
miological data from sub-Saharan Africa are scarce and the 
circulation of EV-C is focused upon in light of the PV eradi-
cation campaign, data from older cohorts like ours are still 
highly relevant. We detected EV in 89.9% of fecal samples 
collected from children between 2002 and 2004 in two hos-
pitals in southern Malawi. This EV frequency is higher than 
in previous studies from sub-Saharan Africa, that reported 
EV prevalence numbers ranging from 1.5% to 50% [15–28]. 
Furthermore, it exceeds the 50% EV prevalence that has pre-
viously been reported in Malawi [26]. This difference might 
be partially explained by several factors. Firstly, in our study, 
we used real time PCR for detection of EV in fecal samples, 
whereas until recently, cell culture and virus isolation was 
the method most often used to detect EVs. 5’UTR PCR has 
been shown to detect EV from clinical specimens with a 
higher sensitivity than cell culture, resulting in higher yields 
especially for the non-B viruses [4, 6, 47]. Secondly, we 
hypothesize that our high EV prevalence is further explained 
by our relatively young population. While other studies often 
focus on a broader age group, EV’s are more prevalent in 
young age groups, when compared to older children and 
adults [15, 19]. Thirdly, the inclusion criteria of the SevAna 
study led to a higher number of participants included during 
the rainy season, in which malaria, a well-known cause of 
anemia, is highly prevalent. Possible seasonal variation in 
EV prevalence, much like in the Western world, might there-
fore have led to a higher detected prevalence in our study.
Interestingly, while we included one sample for each 
study participant, high EV incidence numbers have been 
found in studies that included multiple samples from chil-
dren followed over a longer time-period. One study in Kenya 
showed that in a group of HIV-positive children 92% had 
at least one EV positive fecal sample during a 1-year study 
period [21]. A study conducted in Norway found that 90% 
of healthy children had shed EV at least once during a two-
year follow-up [48].
In our study, 34% of the typed EV strains belonged to spe-
cies EV-C. Although EV-C is a rather rare species in most 
of the world [3, 7, 8, 49–51], it accounts for up to 76% of 
typed EV strains found in African populations [18, 20, 22, 
25–28]. The high proportion of EV-C subgroup C as found 
Table 4  Nucleotide (Nt) and 
amino acid (Aa) identity 
scores; identity scores are given 
within each CVA-13 cluster 
(minimum identity scores), and 
in comparison between CVA-13 
clusters
(range of minimum through maximum identity scores)
Nt identity Aa identity
Within CVA-13 clusters
 Cluster A ≥ 80.6% ≥ 93.1%
 Cluster B ≥ 79.4% ≥ 96.9%
 Cluster C ≥ 78.5% ≥ 93.7%
 Cluster D ≥ 81.5% ≥ 91.5%
 Cluster E ≥ 78.8% ≥ 91.8%
 Cluster F ≥ 89.1% ≥ 95.3%
Between CVA-13 clusters
 Between cluster A, B, C and E 72.3%-77.3% 86.4%-94.0%
 Cluster D compared to cluster A, B, C and E 69.0%-73.3% 79.7%-89.2%
 Cluster F compared to cluster A, B, C, D and E 69.0%-77.0% 82.4%-94.6%
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in our study is in accordance with findings in Cameroon and 
Madagascar. Furthermore, the types within EV-C that were 
most frequently detected in our study (CVA-13, CVA-20, 
EV-C99 and CVA-24) are found in approximately the same 
proportions in Cameroon and Madagascar [27, 52].
We saw a vast genetic diversity within EV-C subgroup C, 
especially within serotype CVA-13. It has been reported by 
others that CVA-13 strains group together in clusters (A-E) 
[27, 46]. In our phylogram, we could see this clustering, 
although cluster B and E were supported by low bootstrap 
values (73% and 33% respectively). Cluster D seems geneti-
cally distinct from the other clusters, with the maximum nt 
identity percentage compared to the other clusters falling 
below 75% (73.3%, table 4). Furthermore, several of the 
CVA-13 strains in our study did not fall within any of the 
clusters. Four of those strains grouped together, possibly 
forming a new cluster ‘F’.
For EV-C99, cluster B in our phylogenetic tree is merely 
supported by a bootstrap value of 5%. This is most likely a 
result of several of our strains grouping close to cluster B. 
Even so, the joint group of cluster B and our strains is sup-
ported by a bootstrap value of merely 25%.
We found PV in two of our samples (one strain PV-2 and 
one strain PV-3). Since the oral polio vaccine is adminis-
tered at birth, this low prevalence is in accordance with our 
participants being between 6 and 60 months of age. The 
PV strains found in our study are most likely derived from 
children who had received a boost dose, or by secondary 
spread of the vaccine.
We found several strains of recently discovered genotypes 
EV-A119, EV-A120 and EV-C116. The prototype strains of 
these genotypes are derived from samples obtained years 
after the collection date of samples analyzed in our study 
[53–55]. We found eight strains of EV-A119, whereas the 
oldest known reference strain dates back to 2008 [52]. 
EV-A119 has only been detected in three children in Cam-
eroon, Côte d’Ivoire and Nigeria [16, 18, 56]. The large pro-
portion of EV-A119 in our database is therefore remarkable. 
In contrast, EV-A71, circulating widely in Asia and Europe, 
and also reported in several studies in sub-Saharan Africa, 
was not detected in our population [7, 27, 57]. Furthermore, 
we found several EV-B genotypes – Echo 1, Echo 15 and 
types EV-B69-100 – that are rarely found in Asia, Europe 
and the US, but seem to be rather prevalent in sub-Saharan 
Africa [7, 18, 27, 28, 57].
The major limitation of our study is the sample collection 
taking place between 2002 and 2004. Over time, the circu-
lation and distribution of genotypes might have changed. 
However, the high diversity within CVA-13 found in our 
study and the repeated isolation of this type throughout the 
whole study period is interesting and suggests continuous 
circulation. Furthermore, making use of sequence based typ-
ing, which was not available at the time of sample collection, 
gives a unique insight into an older sample set, e.g. reveal-
ing circulation of EV-A119 before the first strain was even 
identified.
In conclusion, we found high rates of EV prevalence in 
young children in Malawi and high rates of EV-C – specifi-
cally of subgroup C within EV-C. High EV-C circulation 
is worrying, as strains belonging to this species are able to 
recombine with PV, giving rise to virulent VDPV strains. 
Furthermore, we saw a vast genetic diversity within CVA-
13. Further studies using full length sequences of our study 
strains should reveal whether and to what scale recombined 
EV-C strains containing PV fragments are circulating within 
our population. Moreover, these future studies will also 
show the exact genetic diversity within CVA-13 – focusing 
on the genetic variety of cluster D when compared to the 
other clusters, as well as the genetic diversity of cluster F.
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